SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017406
Filing Date
2022-11-10
Accepted
2022-11-10 16:05:43
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220930x10q.htm   iXBRL 10-Q 1511680
2 EX-31.1 tmb-20220930xex31d1.htm EX-31.1 18453
3 EX-31.2 tmb-20220930xex31d2.htm EX-31.2 18511
4 EX-32.1 tmb-20220930xex32d1.htm EX-32.1 8297
5 EX-32.2 tmb-20220930xex32d2.htm EX-32.2 8785
  Complete submission text file 0001558370-22-017406.txt   6092100

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220930.xsd EX-101.SCH 35420
7 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 49459
8 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 146210
9 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 320044
10 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 259856
49 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930x10q_htm.xml XML 1062314
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 221377034
SIC: 2834 Pharmaceutical Preparations